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Objective: The aim of the present study was to assess the prevalence of Helicobacter
pylori (H. pylori) infection in Kashmiri patients with gastric cancer and to compare this
with a matched control population.
Methods: Fifty patients with gastric cancer and thirty age]sex matched controls were
included in the study. AH the subjects were hailing from Kashmir Valley. For detection
of H. pylori, biopsy specimens were used both from cases and controls.
Results: An insignificant association was shown between H. pylori and both intestinal
and diffuse type of gastric cancer.
Conclusions: The data provides support against the significant association between
H. pylori and gastric cancer in this part of world, a place where the age standardized
incidence of gastric cancer is alarmingly high. We conclude that other factors like
personal and special dietary habits of Kashmiri population may be more important for
the development of gastric cancer.
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INTRODUCTION
Recently population based studies have revealed
an alarmingly high incidence of gastric cancer
in Kashmir (males 36.7/lO0,O00/year, females
9.7/100,000/year) [1]. Little is known about the
factors responsible for this. Studies from other
countries have revealed an increased risk of gas-
tric cancer due to infection with H. pylori. Such a
study has not been conducted in Kashmir Valley
as yet. The present study was undertaken to have
a preliminary viewpoint regarding the association
between gastric cancer and H. pylori in this valley.
The mechanisms involved in the gastric carcino-
genosis due to infection with H. pylori are not
fully understood, but recently a model of the
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chronological changes that occur during the
development of gastric cancer has been proposed.
According to this, H. pylori infection leads to
chronic inflammation of gastric epithelial cells
due to which these cells get damaged at DNA
level which in turn leads to mutation which ulti-
mately culminates in gastric atrophy and intes-
tinal metaplasia and hence gastric cancer [2].
Studies have suggested that the organism is
strongly associated with gastric cancer and lym-
phomas of mucosa associated lymphatic tissue
(MALT) [3].
Evidence supporting a role of H. pylori in gen-
esis of gastric cancer has come from three well
designed seroepidemiological studies [4-6]. These
studies reported that persons who have been
infected with H. pylori upto 25 years previously
had a significantly higher risk of later developing
gastric cancer than those persons who at that
time had not been infected by H. pylori (mean
time between serum collection and diagnosis of
gastric cancer ranged from 6 to 14.2 years). In
these studies, the Odd’s ratio of persons infected
with H. pylori developing gastric cancer ranged
from 2.77 to 9.5.
The Eurogast study group concluded six fold
increase in the risk of gastric cancer in popula-
tions with 100% H. pylori infection compared
with populations that have no infection [7].
Notwithstanding, the results of studies examining
the point prevalence of H. pylori in gastric
cancer patients have varied significantly with some
studies showing the prevalence of this organism
in gastric cancer patients to be similar to or lower
than that in control population [8-11].
The aims of the present study were multifold.
The first was to have a preliminary assessment
regarding the prevalence of H. pylori in patients
with gastric cancer, living in Kashmir Valley, a
place with a high incidence of this cancer. Second
we compared the prevalence of H. pylori infec-
tion in the patient population with an age/sex
matched control population. Third, we examined
the association of H. pylori with both intestinal
and diffuse types of gastric cancer and finally we
attempted to examine the association of H. pylori
with tumours occurring in the region of gastric
antrum and with those occurring in the regions
other than gastric antrum.
MATERIAL AND METHODS
(i) Cases: The cases comprised 50 patients with
gastric cancer. Their mean age+SD was
55.30+ 8.86 years. Of these 50 patients, 42(84%)
were males and 08(16%) were females. There
was no significant difference in age between male
and female cases. These subjects were selected
from the patients referred for endoscopic exami-
nation from the hospitals affiliated to Govern-
ment Medical College, Srinagar. All the subjects
were interviewed regarding drug intake (antibio-
tics, H2 blockers and colloidal bismuth) one
month prior to endoscopic biopsy. Patients, who
had such a history were excluded from the study.
Patients who had gastroesophageal junction
tumours were also excluded from the study. The
diagnosis of the gastric cancer was confirmed by
histopathological examination of biopsy material
after processing. During upper G.I. endoscopy, the
type of gastric growth viz. polypoid, ulcerative,
infiltrative and fungating growth, the rough size of
growth and location of growth either in the corpus
or the fundus, or the antrum were also recorded.
(ii) Controls: The controls comprised 30
healthy volunteers who were apparently free of
any disease and had no history of drug intake
(antibiotics, H2 blockers and colloidal bismuth)
one month prior to endoscopy. They were matched
for both age and sex and all of them were hailing
from the valley.
(iii) Endoscopy and biopsy specimens: All the
cases and controls underwent upper G.I. endo-
scopy using injection diazepam 10mgs I/V as
premedication. The cope used was GIF/GQ-
Olympus. Once growth was seen in cases, multi-
ple (at least two) biopsy specimens were collected
from each of the following sites: (1) within the
cancer itself, (2) the paracancerous area 2cmsH. PYLORI INFECTION IN KASHMIRI PATIENTS 37
distal to the growth, (3) the antrum in those
patients who had growth away from this site and
(4) the corpus and the fundus in those patients
who had antral growth [13].
In controls, multiple biopsies were taken from
the antrum.
The biopsy specimens were subjected to follow-
ing test procedures:
(a) One Minute Endoscopy Room Test
(OMERT): In this test, two biopsy specimens
were put in one ml of 10% W/V freshly prepared
urea solution in deionized water (pH 6.8) at
room temperature. Two drops of 1% phenol red
were added to above solution as an indicator. A
change in colour from yellow to pink observed
1-5 minutes after addition of indicator was
taken as positive test (i.e.H. pylori present),
whereas absence of such colour change or change
of colour after 5 minutes was taken as negative
test [14].
(b) Histology: Biopsy specimens were fixed
in 10% buffered formalin and were processed
routinely [10,15,16]. Paraffin sections (5 am) were
cut and stained with: (1) hematoxylin and eosin
and (2) May-Graunwald-Giemsa stain [13]. The
sections were studied for histopathological fea-
tures of gastric mucosa (gastritis, metaplastic and
mitotic changes) as well as for the presence of
organisms of H. pylori. Gastric cancer was classi-
fied as intestinal or diffuse by the classification
system of Lauren [17].
(c) Gram’s staining: Two biopsy specimens
from each region were rubbed on glass slides
(separate glass slides used for separate site), heat
fixed and then stained with Gram’s stain and
were then studied for presence of H. pylori under
the light microscope [18].
The result obtained, i.e. demonstration of H.
pylori in the biopsy specimen stained by May-
Graunwald-Giemsa stain, was taken as gold
standard as per the current recommendations
[3,12,15,16,19].
(d) Statistical analysis: For statistical analy-
sis the chi-square test was applied. A p-value of
less than 0.05 was considered significant.
(e) Ethics: All subjects gave informed con-
sent for the collection of biopsy tissue. Human
experimentation guidelines of the "Declaration of
Helsinki" were followed and the study was
approved by Principal/Dean, Government Medi-
cal College, Srinagar, after consideration and
approval by members of "Board of Studies".
RESULTS
Prevalence of H. pylori infection & gastric cancer
patients and in controls: Helicobacterpylori posi-
tivity among cases was 17(34%) by histology,
17(34%) by Gram’s staining and 16(32%) by one
minute endoscopy room test (Table I). Two cases
who came positive by histology were not detected
by OMERT and Gram’s staining. However, the
results from histology were taken as gold
standard [3].
Helicobacter pylori positivity among controls
was 10(33.33%) by histology, 9(30%) by Gram’s
staining and 8(26.67%) by OMERT (Table II).
There was one individual among controls who
was positive for H. pylori by histology but nega-
tive by Gram’s staining and OMERT.
Location of the tumour and H. pylori positivity:
Among 50 cases, 26(52%) had growth around the
antral region called antral growth and 24(48%)
01
02
03
TABLE Helicobacter positivity among cases (n 50)
Test No. of cases No. of + ve cases % age
Histology 50 17 34.00
Gram’s Staining 50 17 34.00
One minute endoscopy 50 16 32.00
room test (OMERT)38 G.M. MALIK et al.
cases had growth at the regions other than antrum
called non-antral growth. Out of 26 cases with
antral growth, 11(42.31%) were positive for H.
pylori and among rest 24 cases, 6(25%) were posi-
tive for H. pylori by histology (Table III).
Histological typing of the gastric cancer and
H. pylori status: Among 50 cases, 33(66%)
patients had intestinal type of carcinoma sto-
mach, out of them 11(33.33%) were positive for
H. pylori. The rest 17(34%)cases had diffuse
type of carcinoma stomach of whom only
6(35.29%) were positive for H. pylori (Table IV).
Helicobacter pylori positivity in relation with
biopsy site: Examination of tissue taken from
different biopsy sites in histologically H. pylori
positive gastric cancer patients, has shown organ-
isms to be present in only 10% of the biopsies
taken from cancer area, while the positivity was
more in the biopsies taken from paracancerous
area (50%). The positivity was 62.8% from fundal
biopsies and 80.2% for antral biopsies. The over-
all bacterial load was high with antral biopsies.
Size of tumour and H. pylori positivity: The
prevalence of H. pylori infection in relation to
tumour size was also studied. Among 50 cases,
38(76%) had tumours more than 5cms in size
and 12(24%) had tumours less than 5cms. The
H. pylori positivity in former group was
9(23.68%) and 8(66.66%) in the latter group.
This is a significantly high rate of infection in
individuals with small tumours compared to those
with large tumours of more than 5 cms in size.
Endoscopic type of gastric cancer and H. pylori
positivity: Endoscopically, the growths were
divided in infiltrative, ulcerative, fungating and
polypoid type of growths. The number of such
tumours types and their H. pylori status is
revealed in Table V.
Gastric mucosal histology and H. pylori
positivity: Of 50 cases, the histology of the biopsy
TABLE II Helicobacter positivity among controls (n 30)
Test No. of cases No. of + ve cases % age
01 Histology 30 10 33.33
02 Gram’s Staining 30 09 30.00
03 One minute endoscopy 30 08 26.67
room test (OMERT)
TABLE III Helicobacter pylori positivity with respect to type of growth among
cases (n-- 50)
Type of growth No. (% age) H. pylori positivity by histology
No. (% age)
Antral growths 26 (52.00) 11 (42.31)
Non-antral growths 24 (48.00) 06 (25.00)
TABLE IV Helicobacter pylori positivity with reference to Histological type of growth
among cases (n 50)
Histological type of growth No. (% age) H. pylori positivity by histology
No. (% age)
Intestinal type 33 (66.00) 11 (33.33)
Diffuse type 17 (34.00) 06 (35.29)H. PYLORI INFECTION IN KASHMIRI PATIENTS 39
TABLE V H. pylori positivity in relation to endoscopic type of tumour (n- 50)
Type of tumour No. of cases
No. (%)
H. pylori Positivity by
Histology Gram’s staining OMERT
No. (%) No. (%) No. (%)
Infiltrative 30 (60.00) 12 (40.00) 12 (40.00) 10 (33.33)
Ulcerative 16 (32.00) 04 (25.00) 04 (25.00) 05 (31.25)
Polypoid 04 (8.00) 01 (25.00) 01 (25.00) 01 (25.00)
Total: 50 17 (34.00) 17 (34.00) 16 (32.00)
OMERT One minute Endoscopy room test, Statistical Remarks: X2df2--1.14, (Using histology as gold standard)
p > 0.50, Insignificant.
TABLE VI H. pylori positivity in relation to histological finding of macroscopically normal looking gastric
mucosa among cases (n 50)
Histology No. of cases H. pylori Positivity by
No. (%)
Histology Gram’s staining OMERT
No. (%) No. (%) No. (%)
Normal gastric mucosa 46 (92.00) 14 (30.43) 14 (30.43) 13 (32.51)
Chronic active gastritis 03 (6.00) 02 (66.66) 02 (66.66) 02 (66.66)
Chronic superficial gastritis 01 (2.00) 01 (100.00) 01 (100.00) 01 (100.00)
Total: 50 17 (34.00) 17 (34.00) 16 (32.00)
Statistical Remarks: X2df2 3.63 (Using histology)p > 0.10, Insignificant.
Note: None of our patients had chronic atrophic gastritis or intestinal metaplasia.
TABLE VII H. pylori positivity in relation to histological findings among controls (n-- 30)
Histology No. of cases H. pylori Positivity by
No. (%)
Histology Gram’s staining OMERT
No. (%) No. (%) No. (%)
Normal gastric mucosa 20 (66.66) 05 (25.00) 03 (15.00) 03 (15.00)
Chronic superficial gastritis 06 (20.00) 04 (66.66) 05 (83.33) 04 (66.66)
Chronic active gastritis 04 (13.33) 01 (25.00) 01 (25.00) 01 (25.00)
Total: 30 10 (33.33) 09 (30.00) 08 (26.66)
Statistical Remarks: X2df2- 3.75 (Using histology)p > 0.10, Insignificant.
Note: None of our controls had chronic atrophic gastritis or intestinal metaplasia.
specimen taken at the sites other than cancer site
revealed features as depicted in Table VI.
Similarly among 30 controls, the histopathol-
ogy of biopsy revealed features as depicted in
Table VII.
Comparison of the prevalence rate of H. pylori
infection in gastric cancer patients and controls.
The H. pylori positivity between cases and
controls was compared statistically. The Xadfl
value equaled 0.003 and p value >0.90 which
means an insignificant association between
H. pylori and carcinoma stomach (Table VIII).
The H. pylori positivity and its association to
gastric cancer with respect to type of tumour and
site of tumour are depicted in Tables IX and X.
DISCUSSION
Association between Helicobacter pylori infection
and gastric cancer has been supported by a40 G.M. MALIK et al.
TABLE VIII Relationship between Helicobacter pylori and carcinoma stomach
Group No. of cases Helicobacter positivity Statistical inference
by histology No. (% age)
Cases 50 17 (34.00) X2df 0.003, p > 0.90
Controls 30 10 (33.33) Insignificant
TABLE IX Relationship between H. pylori and antral growths of stomach
Group No. of H. pylori positivity by Statistical inference
cases histology No. (% age)
Antral growths 26 11 (42.31) X-dfl 0.62, p > 0.25
Controls 30 10 (33.33) Insignificant
TABLE X Relationship between H. pylori and intestinal type of carcinoma stomach
Group No. of cases H. pylori positivity by Statistical inference
histology No. (% age)
Cases of intestinal 33
type of carcinoma
Controls 30
11 (33.33) No variation in
incidence rates
10 (33.33) Insignificant
universal phenomenon and until there exists a
satisfactory explanation of the mechanism by
which H. pylori influences gastric carcinogenesis,
a causal link cannot be assumed. The Eurogast
study group [7] has found out 6 fold increased
risk of gastric cancer in populations with 100%
H. pylori infection compared with populations
that have no infection. However, there are places
where despite the fact that the prevalence of H.
pylori infection has been shown to be high, there
is a low incidence of gastric cancer [20, 21].
The valley of Kashmir in the Indian subconti-
nent is a high incidence area of gastric cancer [1].
The prevalence of H. pylori in the normal popu-
lation has been found to be 33.33% by histology,
whereas the present study has shown that in this
area those who developed gastric cancer had no
significant increase in the prevalence of H. pylori
infection. This implies that mere infection with
H. pylori cannot explain such a high incidence of
gastric cancer in this part of world.
The patients who had gastroesophageal junc-
tion growths were excluded from the study
because these growths frequently arise from the
abnormal mucosa in Barett’s esophagus and
therefore cannot be ascribed to H. pylori infec-
tion and hence the confounding effect of Barrett’s
esophagus was removed [6]. Another group of
patients who were excluded from the study were
those who had taken antibiotics, Ha blockers and
colloidal bismuth in the month prior to endo-
scopic examination because the histological
results become less reliable marker of H. pylori
infection [12].
Our study is different from the studies which
support the association between H. pylori and
carcinoma stomach. Such studies have been
undertaken in different parts of world and most
of these studies have used ELISA method for
detection of antibodies against H. pylori. They
have also used different stains for histology
(Giemsa, methylene blue) for detecting H. pylori.
The results obtained from these studies have
shown that by ELISA serology, the results of H.
pylori positivity have been very high as compared
to those found by histology. In other words we
can say that histology underestimates the H.
pylori infectivity. One of the reasons given isH. PYLORI INFECTION IN KASHMIRI PATIENTS 41
that the sensitivity and the specificity of ELISA
are less as compared to histology. Second reason
is that the chances of finding H. pylori in the
biopsy specimens by histology become less when
the changes of chronic atrophic gastritis and
intestinal metaplasia are set in the stomach [22].
These changes although being early steps in the
evolution of gastric cancer in H. pylori infected
patients, yet lead to absence or decrease in the
H. pylori load in gastritis and metaplastic chan-
ged areas of the stomach. This also explains why
the organisms of H. pylori are less frequently
detected from biopsy specimens of the cancerous
site. The reason for such a quantitative change is
not known but it has been postulated that the
organism loses its ecological niche in the stomach
once the atrophic gastritis and metaplastic changes
occur [23].
In our study, none of the cases had above
mentioned pre-cancerous changes, therefore we
believe that detection of H. pylori by histology
has not underestimated the H. pylori infectivity
results as has been reported in other studies [13].
It has been thought that the initiation and pro-
motion of the pre-cancerous lesions i.e. chronic
atrophic gastritis and intestinal metaplasia, by
H. pylori are influenced by several factors includ-
ing gastric hypoacidity, bacterial overgrowth and
diets low in anti-oxidants but high in irritants
and mutagen precursors [2]. Helicobacter pylori
infection among cases and controls almost in
equal percentages (Cases 34% and Controls
33.33%) in this short study rules out this infec-
tion to be a single causal agent for cancer sto-
mach. But we believe that the high incidence of
gastric cancer in Kashmir Valley could also be
due to other factors like diet which is peculiar
among Kashmiri people. Such diets include exces-
sive consumpion of salty tea, pickles, dry fruit,
dried vegetables and leaves of Brassica Olericeaea
(Hak) [1].
In conclusion, the present study does not show
any significant association between H. pylori
infection and gastric cancer in high risk popula-
tion of Kashmir Valley. The association is insig-
nificant for both the types of Leuren’s group of
gastric cancer. Besides present study also con-
cludes an insignificant association between antral
tumours and H. pylori infectivity in Kashmir
Valley. However, further studies especially on a
larger group of patients, are needed to draw any
conclusion in this regard.
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